Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Gill

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Pediatrics in Review|September 3, 2011
Inherited hematologic and oncologic syndromesJonathan Gill
Nature Reviews. Clinical Oncology|June 16, 2021
Advancing therapy for osteosarcomaJonathan Gill, Richard Gorlick
Advances in Experimental Medicine and Biology|June 14, 2014
HER-2 involvement in osteosarcomaJonathan Gill, David Geller, Richard Gorlick
Journal of Vision|May 29, 2012
Anatomical constraints on attention: hemifield independence is a signature of multifocal spatial selectionGeorge A Alvarez, Jonathan Gill, Patrick Cavanagh
Advances in Experimental Medicine and Biology|June 3, 2020
HER2-Targeted Therapy in OsteosarcomaJonathan Gill, Pooja Hingorani, Michael Roth, et al.
Cancer Journal (Sudbury, Mass.)|November 28, 2018
Challenges of Clinical Management of Adolescent and Young Adults With Bone and Soft Tissue SarcomaAndrea Ferrari, Patrizia Gasparini, Jonathan Gill, et al.
Sarcoma|June 2, 2018
High-Dose Chemotherapy with Stem Cell Rescue in Desmoplastic Small Round Cell Tumor: A Single-Institution Experience and Review of the LiteratureKayleen Bailey, Michael Roth, Daniel Weiser, et al.
Radiology Case Reports|August 23, 2017
Radiological difficulty in identifying unicompartmental knee replacement dislocationOruaro Adebayo Onibere, Iain Stevenson, Fraser Jonathan Gill
Pharmacology & Therapeutics|September 18, 2012
New targets and approaches in osteosarcomaJonathan Gill, Manpreet K Ahluwalia, David Geller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2015
To B(MP-2) or Not To B(MP-2): Cytokines and Tumor Surgery—LetterDavid S Geller, Jonathan Gill, Michael Roth, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Pediatrics in Review|September 3, 2011
Inherited hematologic and oncologic syndromesJonathan Gill
Nature Reviews. Clinical Oncology|June 16, 2021
Advancing therapy for osteosarcomaJonathan Gill, Richard Gorlick
Advances in Experimental Medicine and Biology|June 14, 2014
HER-2 involvement in osteosarcomaJonathan Gill, David Geller, Richard Gorlick
Journal of Vision|May 29, 2012
Anatomical constraints on attention: hemifield independence is a signature of multifocal spatial selectionGeorge A Alvarez, Jonathan Gill, Patrick Cavanagh
Advances in Experimental Medicine and Biology|June 3, 2020
HER2-Targeted Therapy in OsteosarcomaJonathan Gill, Pooja Hingorani, Michael Roth, et al.
Cancer Journal (Sudbury, Mass.)|November 28, 2018
Challenges of Clinical Management of Adolescent and Young Adults With Bone and Soft Tissue SarcomaAndrea Ferrari, Patrizia Gasparini, Jonathan Gill, et al.
Sarcoma|June 2, 2018
High-Dose Chemotherapy with Stem Cell Rescue in Desmoplastic Small Round Cell Tumor: A Single-Institution Experience and Review of the LiteratureKayleen Bailey, Michael Roth, Daniel Weiser, et al.
Radiology Case Reports|August 23, 2017
Radiological difficulty in identifying unicompartmental knee replacement dislocationOruaro Adebayo Onibere, Iain Stevenson, Fraser Jonathan Gill
Pharmacology & Therapeutics|September 18, 2012
New targets and approaches in osteosarcomaJonathan Gill, Manpreet K Ahluwalia, David Geller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2015
To B(MP-2) or Not To B(MP-2): Cytokines and Tumor Surgery—LetterDavid S Geller, Jonathan Gill, Michael Roth, et al.
Pageof 7